Medroxyprogesterone Acetate Injection, Suspension, Extended Release
Product Images NDC 0548-5711

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 0548-5711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amphastar Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-stock 5411-25-pack (25 Pack Vial Carton)

Carton-stock 5411-25-pack (25 Pack Vial Carton)
This is a description of an injectable medication contained in vials that are single-use with 1 mL capacity each. The medication contains Madroxyprogestarons acetat at a concentration of 150 mg, and also includes polyethylene glycol 2350, polysorbata 80, sodium cloide, and preservatives such as mathyparaben and propyparaben at specific concentrations. The medication should be stored at room temperature, tightly sealed and should be shaken before use. The complete product information is available on the package insert with details regarding dosage and administration.*
FDA Label Image

Figure1 (Figure1)

FDA Label Image

Chemical Structure (Medroxyprogesterone 01)

FDA Label Image

Figure 1 (Medroxyprogesterone 02)

FDA Label Image

Figure 2 (Medroxyprogesterone 03)

FDA Label Image

Chart (Medroxyprogesterone 04)

Chart (Medroxyprogesterone 04)
This text provides information on various birth control methods and their effectiveness. The first part of the text gives statistics on the number of pregnancies per 100 women in a year using various birth control methods. The methods listed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the fertile days of the monthly cycle, spermicide, and withdrawal. The final line indicates that there is no information on the effectiveness of using no birth control.*
FDA Label Image

Novaplus1 (Novaplus1)

FDA Label Image

Novaplus2 (Novaplus2)

FDA Label Image

Carton-stock 5410 (Single Pack Vial Carton)

FDA Label Image

Carton-stock 5711 (Syringe Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.